In this videocast interview from the International AIDS Society Conference in Sydney, Peter Staley asks Professor Simon Mallal from the Royal Perth Hospital about a simple new genetic test that accurately predicts if a patient is at risk for an allergic reaction to abacavir (an NRTI known by its brand name Ziagen, and one of the drugs in Epzicom and Trizivir).

To read more about this topic click here.